U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

von Willebrand disease type 2M(VWD2M)

MedGen UID:
266186
Concept ID:
C1282974
Disease or Syndrome
Synonym: VWD2M
Modes of inheritance:
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
 
Monarch Initiative: MONDO:0015630
OMIM®: 613160; 613554
Orphanet: ORPHA166090

Definition

A subtype of type 2 von Willebrand disease characterized by a bleeding disorder associated with decreased affinity of the Willebrand factor (VWF) for platelets or collagen in the absence of any deficiency of high molecular weight VWF multimers. The disease manifests as mucocutaneous bleeding (menorrhagia, epistaxis, gastrointestinal hemorrhage, etc.). [from ORDO]

Professional guidelines

PubMed

Woods AI, Paiva J, Primrose DM, Blanco AN, Sanchez-Luceros A
J Thromb Haemost 2022 Apr;20(4):1022-1023. doi: 10.1111/jth.15644. PMID: 35307945
Favaloro EJ
J Thromb Haemost 2022 Apr;20(4):1019-1021. doi: 10.1111/jth.15645. PMID: 35307944
Maas DPMSM, Atiq F, Blijlevens NMA, Brons PPT, Krouwel S, Laros-van Gorkom BAP, Leebeek FWG, Nieuwenhuizen L, Schoormans SCM, Simons A, Meijer D, van Heerde WL, Schols SEM
J Thromb Haemost 2022 Feb;20(2):316-327. Epub 2021 Nov 21 doi: 10.1111/jth.15586. PMID: 34758185Free PMC Article

Recent clinical studies

Diagnosis

Maas DPMSM, Atiq F, Blijlevens NMA, Brons PPT, Krouwel S, Laros-van Gorkom BAP, Leebeek FWG, Nieuwenhuizen L, Schoormans SCM, Simons A, Meijer D, van Heerde WL, Schols SEM
J Thromb Haemost 2022 Feb;20(2):316-327. Epub 2021 Nov 21 doi: 10.1111/jth.15586. PMID: 34758185Free PMC Article
Gadisseur A, van der Planken M, Schroyens W, Berneman Z, Michiels JJ
Acta Haematol 2009;121(2-3):145-53. Epub 2009 Jun 8 doi: 10.1159/000214855. PMID: 19506361
Hermans C, Batlle J
Acta Haematol 2009;121(2-3):139-44. Epub 2009 Jun 8 doi: 10.1159/000214854. PMID: 19506360

Therapy

Gadisseur A, van der Planken M, Schroyens W, Berneman Z, Michiels JJ
Acta Haematol 2009;121(2-3):145-53. Epub 2009 Jun 8 doi: 10.1159/000214855. PMID: 19506361
Mauz-Körholz C, Budde U, Körholz D, Göbel U
Eur J Pediatr 1999 Dec;158 Suppl 3:S174-6. doi: 10.1007/pl00014349. PMID: 10650863

Clinical prediction guides

Sandoval-Pérez A, Mejía-Restrepo V, Aponte-Santamaría C
Proteins 2022 Dec;90(12):2058-2066. Epub 2022 Jul 22 doi: 10.1002/prot.26397. PMID: 35833249
Maas DPMSM, Atiq F, Blijlevens NMA, Brons PPT, Krouwel S, Laros-van Gorkom BAP, Leebeek FWG, Nieuwenhuizen L, Schoormans SCM, Simons A, Meijer D, van Heerde WL, Schols SEM
J Thromb Haemost 2022 Feb;20(2):316-327. Epub 2021 Nov 21 doi: 10.1111/jth.15586. PMID: 34758185Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...